Zepbound contains tirzepatide, a medication that acts on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These hormones influence appetite, digestion, and blood sugar regulation. The medication is administered as a once-weekly injection alongside reduced-calorie eating and increased physical activity for eligible individuals.
Zepbound affects several processes involved in appetite and digestion. By influencing hormone receptors, it can increase feelings of fullness, reduce hunger, and slow stomach emptying. These effects may contribute to reduced food intake and changes in body weight.
However, the medication can also produce gastrointestinal reactions, particularly when starting treatment or increasing the dosage. The severity and duration of side effects vary between individuals.
Common side effects include:
Nausea: Some individuals experience nausea, particularly during the initial stages of treatment.
Diarrhea: Changes in digestion may result in frequent or loose bowel movements.
Constipation: Slower movement of food through the digestive system can contribute to constipation.
Vomiting: Some individuals experience vomiting, especially when gastrointestinal symptoms become more noticeable.
Abdominal discomfort: Stomach pain, bloating, and indigestion may occur during treatment.
Injection site reactions: Redness, itching, or discomfort can develop where the medication is administered.
Fatigue: Some individuals report tiredness or reduced energy during treatment.
Most common gastrointestinal reactions may become less noticeable as the body adjusts. However, persistent or severe symptoms should be discussed with a healthcare professional.
Weight management involves more than reducing appetite or body weight. Individuals using Zepbound should consider nutritional intake, hydration, physical activity, and overall health throughout treatment.
A balanced eating pattern helps maintain adequate nutrient intake while supporting weight-related goals. Including protein-rich foods, vegetables, fruits, whole grains, and appropriate portions can help support general nutritional needs.
Important weight management considerations include:
Balanced nutrition: Maintain a varied diet that provides sufficient protein, vitamins, minerals, and dietary fibre.
Hydration: Drink adequate water, particularly when experiencing vomiting or diarrhea.
Physical activity: Regular walking, resistance exercises, and other suitable activities can support muscle maintenance and general fitness.
Meal portions: Smaller meals may help individuals manage feelings of fullness and gastrointestinal discomfort.
Weight monitoring: Track weight changes and discuss unexpected changes with a healthcare professional.
Medical supervision: Follow prescribed dosage instructions and attend recommended medical appointments.
Certain serious risks also require attention. Zepbound carries a boxed warning concerning thyroid C-cell tumors observed in animal studies. Its relevance to humans remains unknown. It should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
Other serious concerns include pancreatitis, gallbladder problems, kidney injury related to dehydration, severe allergic reactions, and hypoglycemia, particularly when combined with certain diabetes medications. Severe abdominal pain, difficulty breathing, or persistent vomiting requires prompt medical attention.